Wolfson, LJ, et al.
Estimates of measles case fatality ratios: a comprehensive review of community-based studies. International Journal of Epidemiology
2009; 38: 192–205.
Liu, L, et al.
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet
2014; 385: 430–440.
van den Ent, MMVX, et al.
Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990–2008. Journal of Infectious Diseases
2011; 204 (Suppl. 1): S18–S23.
Lessler, J, et al.
Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. PLoS Medicine
2011; 8: 1–10.
Castillo-Solorzano, C, et al.
Measles and rubella elimination initiatives in the Americas: lessons learned and best practices. Journal of Infectious Diseases
2011; 204 (Suppl. 1): S279–S283.
Zipprich, J, et al.
Measles outbreak – California, December 2014–February 2015. Morbidity and Mortality Weekly Report
2015; 64: 153–154.
Castillo-Solorzano, C, et al.
The Americas: paving the road toward global measles eradication. Journal of Infectious Diseases
2011; 204 (Suppl. 1): S270–S278.
McLean, AR, Anderson, RM. Measles in developing countries. Part I. Epidemiological parameters and patterns. Epidemiology and Infection
1988; 100: 111–133.
McLean, AR, Anderson, RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiology and Infection
1988; 100: 419–442.
Niewiesk, S, Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Frontiers in Immunology
2014; 5: 1–15.
Brugha, R, et al.
A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiology and Infection
1996; 117: 519–524.
Cutts, FT, Grabowsky, M, Markowitz, LE. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals
1995; 23: 95–106.
Gans, H, et al.
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. Journal of Infectious Diseases
2001; 184: 817–826.
McKee, A, Ferrari, MJ, Shea, K. The effects of maternal immunity and age structure on population immunity to measles. Theoretical Ecology
2015; 8: 261–271.
Prevots, D, et al.
Interruption of measles transmission in Brazil, 2000–2001. Journal of Infectious Diseases
2003; 187 (Suppl. 1): S111–S120.
Kidd, S, et al.
Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness. Vaccine
2012; 30: 5000–5008.
Minetti, A, et al.
Lessons and challenges for measles control from unexpected large outbreak, Malawi. Emerging Infectious Diseases
2013; 19: 202–9.
Moore, C, et al.
Self-collected buccal swabs and rapid, real-time PCR during a large measles outbreak in Wales: evidence for the protective effect of prior MMR immunisation. Journal of Clinical Virology
2015; 67: 1–7.
Leite, RD, Barreto, JLTMS, Sousa, AQ. Measles reemergence in Ceará, Northeast Brazil, 15 years after elimination. Emerging Infectious Diseases
2015; 21: 1681–1683.
Zhao, H, et al.
Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination. Virology Journal
2010; 7: 1–6.
Leuridan, E, et al.
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. British Medical Journal
2010; 340: c1626–c1626.
Ciofi degli Atti, ML, et al.
Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine
2004; 22: 4351–4357.
Thompson, KM, et al.
Synthesis of evidence to characterize national measles and rubella exposure and immunization histories. Risk Analysis
2016; 36: 1427–1458.